✦ LIBER ✦

High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast

✍ Scribed by Schwartzberg, L S; Weaver, C H; Lewkow, L; McAneny, B; Zhen, B; Birch, R; West, W H; Tauer, K W; Buckner, C D

Book ID: 110012203
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 67 KB
Volume: 24
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1701965

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose chemotherapy for refractory ur

High dose chemotherapy for refractory urothelial carcinoma supported by peripheral blood stem cell transplantation

✍ Masanori Nishimura; Kaori Nasu; Hitoya Ohta; Masayuki Shintaku; Youichi Takahash 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

## BACKGROUND. Chemotherapy with methotrexate (MTX), vinblastine, doxorubicin, and cisplatin (M-VAC) is reported to be the most effective regimen for urothelial carcinoma. Complete response (CR) is observed in many cases. However, to the authors' knowledge there is no alternative therapy for nonre

Adjuvant high-dose therapy with peripher

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer

✍ S. Hohaus; S. Martin; A. Schneeweiß; M. T. Voso; R. F. Schlenk; D. Wallwiener; G 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 105 KB

Preoperative high-dose chemotherapy with

Preoperative high-dose chemotherapy with peripheral blood stem cell support as a primary management of locally advanced breast cancer

✍ Wang, X; Tang, J; Wu, J; Feng, J; Pang, L; Dai, A; Zheng, X 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 34 KB

High dose chemotherapy with autologous s

High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer

✍ Lois J. Ayash 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

Peripheral blood stem cell mobilization

Peripheral blood stem cell mobilization for hematopoietic support of radioimmunotherapy in patients with breast carcinoma

✍ Carol M. Richman; Tina C. Schuermann; Theodore Wun; Rajiv Malik; Robert T. O'Don 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

BACKGROUND. In clinical trials of radiolabeled monoclonal antibodies targeting

High dose chemotherapy and autologous bl

High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastases

✍ Rick Abraham; Tracy Nagy; Paul E. Goss; Michael Crump 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

## BACKGROUND. The prognosis of patients with isolated supraclavicular lymph node (SCN) metastases is similar to patients with metastatic breast carcinoma involving other sites. Because these patients have a lower disease burden compared with women with distant metastases, their outcome after high